Banner
Global Artificial Intelligence In Cancer Diagnostics Market Report 2024

Artificial Intelligence In Cancer Diagnostics Global Market Report 2024 – By Component (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Types), By Application (Screening And Diagnosis, Tumor Identification, Surveillance, Treatment), By End-User (Hospitals, Medical Research Institute, Diagnostic Centers, Contract Research Organization) – Market Size, Trends, And Global Forecast 2024-2033

Artificial Intelligence In Cancer Diagnostics Global Market Report 2024

Starting Price : $4000.00 $3200.00 | Pages : | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Artificial Intelligence In Cancer Diagnostics Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

Artificial Intelligence In Cancer Diagnostics Market Definition

Artificial intelligence (AI) in cancer diagnostics refers to the use of advanced computational techniques and algorithms to assist in detecting, diagnosing, and characterizing cancer. Artificial intelligence (AI) is used in cancer diagnostics to improve the speed, accuracy, and efficiency of cancer imaging tests and to detect mammographic abnormalities with comparable accuracy to radiologists.

The main components of artificial intelligence in cancer diagnostics are software solutions, hardware, and services. Software solutions refer to customized software applications or systems developed to address specific business needs or solve particular problems and AI-powered software solutions utilize machine learning algorithms and computer vision techniques to analyze medical images, genetic data, and clinical records, enabling accurate cancer detection, classification, and treatment prediction. They are used in breast cancer, lung cancer, prostate cancer, colorectal cancer, brain tumors, and others for applications such as screening and diagnosis, tumor identification, surveillance, and treatment, and are used by hospitals, medical research institutes, diagnostic centers, and contract research organizations.

Artificial Intelligence In Cancer Diagnostics Market Segmentation

The artificial intelligence in cancer diagnostics market covered in this report is segmented –

1) By Component: Software Solutions, Hardware, Services

2) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Types

3) By Application: Screening And Diagnosis, Tumor Identification, Surveillance, Treatment

4) By End-User: Hospitals, Medical Research Institute, Diagnostic Centers, Contract Research Organization

Global Artificial Intelligence In Cancer Diagnostics Market Size 2023 to 2028: Graph

Artificial Intelligence In Cancer Diagnostics Market Size 2024 And Growth Rate

The artificial intelligence in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.3 billion in 2023 to $0.4 billion in 2024 at a compound annual growth rate (CAGR) of 34.0%. The growth in the historic period can be attributed to increased cancer incidence, big data availability, rise of personalized oncology, precision medicine initiatives, integration of genomic data.

Artificial Intelligence In Cancer Diagnostics Market Growth Forecast

The artificial intelligence in cancer diagnostics market size is expected to see exponential growth in the next few years. It will grow to $1.18 billion in 2028 at a compound annual growth rate (CAGR) of 30.8%. The growth in the forecast period can be attributed to clinician shortages, population aging, global telemedicine adoption, integration of ai with electronic health records, growing cancer screening programs. Major trends in the forecast period include rapid advances in ai algorithms, advancements in imaging technology, technological innovations in pathology, advancements in radiomics and radiogenomics, drug development, deep learning, ai for predictive biomarker discovery.

Artificial Intelligence In Cancer Diagnostics Market Driver: Revolutionizing Cancer Care Artificial Intelligence Emerges As A Key Player In Advancing Cancer Diagnostics

The rising prevalence of cancer is expected to propel the growth of artificial intelligence in the cancer diagnostics market going forward. Cancer refers to uncontrolled cell growth, which impacts various organs and contributes to significant morbidity and mortality worldwide. Artificial intelligence is utilized in cancer diagnostics for accurate and efficient analysis of medical imaging data, aiding in the early detection and precise classification of cancerous lesions. For instance, in October 2023, according to the European Union Science Hub, a Belgium-based European Commission's joint research center, the number of new cases of cancer increased by 2.3% to 2.74 million in 2022 in comparison to the past 2 years. Similarly, cancer-related mortality increased by 2.4% during the preceding two years. Therefore, the rising prevalence of cancer is expected to propel the growth of artificial intelligence in the cancer diagnostics market.

Artificial Intelligence In Cancer Diagnostics Market Driver: Healthcare Infrastructure Upgrades Fuel The Growth Of Artificial Intelligence In Cancer Diagnostics

The rising improvement of healthcare infrastructure is expected to propel the growth of artificial intelligence in cancer diagnostics market in the coming years. Healthcare infrastructure refers to the basic framework, buildings, resources, and processes that collectively enable the provision of healthcare services within a certain region or community. AI in cancer diagnostics requires a well-established and interoperable healthcare infrastructure that allows for the smooth integration of AI technologies into clinical workflows, maintains data security and privacy, and facilitates collaborative efforts across healthcare institutions. For instance, in March 2022, the Department of Health and Aged Care, an Australia-based government agency responsible for financing, promoting, regulating, and conducting health research, announced that the newly elected Coalition is going to allocate a record $132 billion to healthcare infrastructure in 2022–23, rising to $140 billion in 2025–26 for an overall commitment of $537 billion throughout the next four years. Therefore, the rising improvement of healthcare infrastructure is driving artificial intelligence in cancer diagnostics market.

Global Artificial Intelligence In Cancer Diagnostics Market Major Players

Major companies operating in the artificial intelligence in cancer diagnostics market report are Microsoft Corporation, Pfizer Inc., Johnson & Johnson's, Siemens, Roche Holding AG, Google LCC, International Business Machines Corporation, Thermo Fisher Scientific Inc., Oracle Corporation, GE Healthcare, Illumina Inc., Bio Rad Laboratories Inc., Flatiron Health, Tempus Labs Inc., Paige AI Inc., OncoHealth Corporation, Path AI Inc., Aidoc, AliveCor Inc., Sophia Genetics SA, Digital Diagnostics Inc., Prognos Health, Aidence, Kheiron Medical Technologies Limited, Zebra Medical Vision, Niramai, Enlitic Inc., Therapixel, Medial EarlySign Ltd., Freenome, SkinVision B.V.

Global Artificial Intelligence In Cancer Diagnostics Market Trend: Ai-Powered Breakthrough In Cancer Diagnostics

Technological advancement is a key trend gaining popularity in artificial intelligence in the cancer diagnostics market. Major companies operating in the market are concentrating on creating innovative tools for various cancer conditions and sustaining their position in the market. For instance, in March 2023, Qritive, a Singapore-based company engaged in AI-powered solutions to support pathologists, launched QAi Prostate, a new AI-powered tool for prostate cancer diagnosis. QAi Prostate can accurately identify prostatic adenocarcinoma regions and classify malignant and benign tumor areas in biopsy tissue samples. The tool provides a detailed summary of the tumor size and percentage for each slide or region of interest (ROI), allowing pathologists to make more informed decisions quickly.

Global Artificial Intelligence In Cancer Diagnostics Market Trend: Strategic Collaborations Drive Rapid Deployment Of Ai-Powered Digital Pathology Technologies

Major companies operating in the artificial intelligence in cancer diagnostics market are focusing on strategic collaboration to expedite the deployment of AI-powered digital pathology technologies to aid in cancer diagnosis. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in October 2023, F. Hoffmann-La Roche AG, a Switzerland-based diagnostics and pharmaceutical company, announced a collaboration with Ibex Medical Analytics, an Israel-based medical technology company, and Amazon Web Services, Inc., a US-based comprehensive and broadly adopted cloud, allowing pathology labs to use the navify Digital Pathology software platform to access Ibex's AI-powered decision support capabilities to assist physicians in diagnosing breast and prostate cancer. The cooperation of Ibex Medical Analytics and Roche is generating innovative AI-powered processes to assist pathologists and laboratories in realizing the full promise of turning digital. The cloud-based digital pathology and AI solutions from Roche and Ibex are powered by Amazon Web Services (AWS), offering a scalable and sustainable environment for pathology laboratories.

Artificial Intelligence In Cancer Diagnostics Market Merger And Acquisition: Radnet Bolsters Cancer Diagnostics Capabilities Acquires Aidence Holding And Quantib To Power AI In Lung And Prostate Cancer Screening

In January 2022, RadNet, a US-based company engaged in radiology information technology solutions, acquired Aidence Holding B.V. and Quantib B.V. for an undisclosed amount. With this acquisition, RadNet addresses opportunities in lung and prostate cancer diagnosis and screening with artificial intelligence. Aidence Holding B.V. is a Netherlands-based company engaged in AI-powered clinical applications for the lung cancer pathway. Quantib B.V. is a Netherlands-based AI, and machine-learning company focused on clinical solutions for prostate cancer.

Regional Outlook For The Global Artificial Intelligence In Cancer Diagnostics Market

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial intelligence in cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The artificial intelligence (AI) in the cancer diagnostics market consists of revenues earned by entities by providing services such as data analysis, image recognition, personalized medicine, and decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the cancer diagnostics market also includes sales of AI-based diagnostic tools, predictive analytics tools, and a virtual tumor board. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The artificial intelligence in cancer diagnostics research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in cancer diagnostics market statistics, including the artificial intelligence in cancer diagnostics industry's global market size, regional shares, competitors with an artificial intelligence in cancer diagnostics market share, detailed artificial intelligence in cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in cancer diagnostics industry. This artificial intelligence in cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Artificial Intelligence In Cancer Diagnostics Market Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $0.4 billion
Revenue Forecast In 2033 $1.18 billion
Growth Rate CAGR of 30.8% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Component: Software Solutions, Hardware, Services
2) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Types
3) By Application: Screening And Diagnosis, Tumor Identification, Surveillance, Treatment
4) By End-User: Hospitals, Medical Research Institute, Diagnostic Centers, Contract Research Organization
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Microsoft Corporation; Pfizer Inc.; Johnson & Johnson's; Siemens; Roche Holding AG; Google LCC; International Business Machines Corporation; Thermo Fisher Scientific Inc.; Oracle Corporation; GE Healthcare; Illumina Inc.; Bio Rad Laboratories Inc.; Flatiron Health; Tempus Labs Inc.; Paige AI Inc.; OncoHealth Corporation; Path AI Inc.; Aidoc; AliveCor Inc.; Sophia Genetics SA; Digital Diagnostics Inc.; Prognos Health; Aidence; Kheiron Medical Technologies Limited; Zebra Medical Vision; Niramai; Enlitic Inc.; Therapixel; Medial EarlySign Ltd.; Freenome; SkinVision B.V.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Artificial Intelligence In Cancer Diagnostics Market Characteristics

    3. Artificial Intelligence In Cancer Diagnostics Market Trends And Strategies

    4. Artificial Intelligence In Cancer Diagnostics Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Artificial Intelligence In Cancer Diagnostics Market Size and Growth

    5.1. Global Artificial Intelligence In Cancer Diagnostics Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Artificial Intelligence In Cancer Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Artificial Intelligence In Cancer Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Artificial Intelligence In Cancer Diagnostics Market Segmentation

    6.1. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Software Solutions

    Hardware

    Services

    6.2. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Breast Cancer

    Lung Cancer

    Prostate Cancer

    Colorectal Cancer

    Brain Tumor

    Other Types

    6.3. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Screening And Diagnosis

    Tumor Identification

    Surveillance

    Treatment

    6.4. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Medical Research Institute

    Diagnostic Centers

    Contract Research Organization

    7. Artificial Intelligence In Cancer Diagnostics Market Regional And Country Analysis

    7.1. Global Artificial Intelligence In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Artificial Intelligence In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market

    8.1. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Artificial Intelligence In Cancer Diagnostics Market

    9.1. China Artificial Intelligence In Cancer Diagnostics Market Overview

    9.2. China Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Artificial Intelligence In Cancer Diagnostics Market

    10.1. India Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Artificial Intelligence In Cancer Diagnostics Market

    11.1. Japan Artificial Intelligence In Cancer Diagnostics Market Overview

    11.2. Japan Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Artificial Intelligence In Cancer Diagnostics Market

    12.1. Australia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Artificial Intelligence In Cancer Diagnostics Market

    13.1. Indonesia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Artificial Intelligence In Cancer Diagnostics Market

    14.1. South Korea Artificial Intelligence In Cancer Diagnostics Market Overview

    14.2. South Korea Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Artificial Intelligence In Cancer Diagnostics Market

    15.1. Western Europe Artificial Intelligence In Cancer Diagnostics Market Overview

    15.2. Western Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Artificial Intelligence In Cancer Diagnostics Market

    16.1. UK Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Artificial Intelligence In Cancer Diagnostics Market

    17.1. Germany Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Artificial Intelligence In Cancer Diagnostics Market

    18.5. France Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Artificial Intelligence In Cancer Diagnostics Market

    19.9. Italy Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Artificial Intelligence In Cancer Diagnostics Market

    20.13. Spain Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market

    21.1. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market Overview

    21.2. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Artificial Intelligence In Cancer Diagnostics Market

    22.1. Russia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Artificial Intelligence In Cancer Diagnostics Market

    23.1. North America Artificial Intelligence In Cancer Diagnostics Market Overview

    23.2. North America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Artificial Intelligence In Cancer Diagnostics Market

    24.1. USA Artificial Intelligence In Cancer Diagnostics Market Overview

    24.2. USA Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Artificial Intelligence In Cancer Diagnostics Market

    25.1. Canada Artificial Intelligence In Cancer Diagnostics Market Overview

    25.2. Canada Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Artificial Intelligence In Cancer Diagnostics Market

    26.1. South America Artificial Intelligence In Cancer Diagnostics Market Overview

    26.2. South America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Artificial Intelligence In Cancer Diagnostics Market

    27.1. Brazil Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Artificial Intelligence In Cancer Diagnostics Market

    28.1. Middle East Artificial Intelligence In Cancer Diagnostics Market Overview

    28.2. Middle East Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Artificial Intelligence In Cancer Diagnostics Market

    29.1. Africa Artificial Intelligence In Cancer Diagnostics Market Overview

    29.2. Africa Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Artificial Intelligence In Cancer Diagnostics Market Competitive Landscape And Company Profiles

    30.1. Artificial Intelligence In Cancer Diagnostics Market Competitive Landscape

    30.2. Artificial Intelligence In Cancer Diagnostics Market Company Profiles

    30.2.1. Microsoft Corporation

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Pfizer Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Johnson & Johnson's

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Siemens

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Roche Holding AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Artificial Intelligence In Cancer Diagnostics Market Other Major And Innovative Companies

    31.1. Google LCC

    31.2. International Business Machines Corporation

    31.3. Thermo Fisher Scientific Inc.

    31.4. Oracle Corporation

    31.5. GE Healthcare

    31.6. Illumina Inc.

    31.7. Bio Rad Laboratories Inc.

    31.8. Flatiron Health

    31.9. Tempus Labs Inc.

    31.10. Paige AI Inc.

    31.11. OncoHealth Corporation

    31.12. Path AI Inc.

    31.13. Aidoc

    31.14. AliveCor Inc.

    31.15. Sophia Genetics SA

    32. Global Artificial Intelligence In Cancer Diagnostics Market Competitive Benchmarking

    33. Global Artificial Intelligence In Cancer Diagnostics Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Artificial Intelligence In Cancer Diagnostics Market

    35. Artificial Intelligence In Cancer Diagnostics Market Future Outlook and Potential Analysis

    35.1 Artificial Intelligence In Cancer Diagnostics Market In 2028 - Countries Offering Most New Opportunities

    35.2 Artificial Intelligence In Cancer Diagnostics Market In 2028 - Segments Offering Most New Opportunities

    35.3 Artificial Intelligence In Cancer Diagnostics Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Artificial Intelligence In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Artificial Intelligence In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Microsoft Corporation Financial Performance
  • Table 76: Pfizer Inc. Financial Performance
  • Table 77: Johnson & Johnson's Financial Performance
  • Table 78: Siemens Financial Performance
  • Table 79: Roche Holding AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Artificial Intelligence In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Artificial Intelligence In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Microsoft Corporation Financial Performance
  • Figure 76: Pfizer Inc. Financial Performance
  • Figure 77: Johnson & Johnson's Financial Performance
  • Figure 78: Siemens Financial Performance
  • Figure 79: Roche Holding AG Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the artificial intelligence in cancer diagnostics market?

Artificial intelligence (AI) in cancer diagnostics refers to the use of advanced computational techniques and algorithms to assist in detecting, diagnosing, and characterizing cancer. Artificial intelligence (AI) is used in cancer diagnostics to improve the speed, accuracy, and efficiency of cancer imaging tests and to detect mammographic abnormalities with comparable accuracy to radiologists. For further insights on the artificial intelligence in cancer diagnostics market, request a sample here

How will the artificial intelligence in cancer diagnostics market drivers and restraints affect the artificial intelligence in cancer diagnostics market dynamics? What forces will shape the artificial intelligence in cancer diagnostics industry going forw

The artificial intelligence in cancer diagnostics market major growth driver - Revolutionizing Cancer Care Artificial Intelligence Emerges As A Key Player In Advancing Cancer Diagnostics. For further insights on the artificial intelligence in cancer diagn request a sample here

What is the forecast market size or the forecast market value of the artificial intelligence in cancer diagnostics market?

The artificial intelligence in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.3 billion in 2023 to $0.4 billion in 2024 at a compound annual growth rate (CAGR) of 34.0%. The growth in the historic period can be attributed to increased cancer incidence, big data availability, rise of personalized oncology, precision medicine initiatives, integration of genomic data. The artificial intelligence in cancer diagnostics market size is expected to see exponential growth in the next few years. It will grow to $1.18 billion in 2028 at a compound annual growth rate (CAGR) of 30.8%. The growth in the forecast period can be attributed to clinician shortages, population aging, global telemedicine adoption, integration of ai with electronic health records, growing cancer screening programs. Major trends in the forecast period include rapid advances in ai algorithms, advancements in imaging technology, technological innovations in pathology, advancements in radiomics and radiogenomics, drug development, deep learning, ai for predictive biomarker discovery. For further insights on the artificial intelligence in cancer diagnostics market, request a sample here

How is the artificial intelligence in cancer diagnostics market segmented?

The artificial intelligence in cancer diagnostics market is segmented
1) By Component: Software Solutions, Hardware, Services
2) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Types
3) By Application: Screening And Diagnosis, Tumor Identification, Surveillance, Treatment
4) By End-User: Hospitals, Medical Research Institute, Diagnostic Centers, Contract Research OrganizationFor further insights on the artificial intelligence in cancer diagnostics market,
request a sample here

Which region has the largest share of the artificial intelligence in cancer diagnostics market? What are the other regions covered in the report?

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the artificial intelligence in cancer diagnostics market, request a sample here.

Who are the major players in the artificial intelligence in cancer diagnostics market?

Major companies operating in the artificial intelligence in cancer diagnostics market report are Microsoft Corporation, Pfizer Inc., Johnson & Johnson's, Siemens, Roche Holding AG, Google LCC, International Business Machines Corporation, Thermo Fisher Scientific Inc., Oracle Corporation, GE Healthcare, Illumina Inc., Bio Rad Laboratories Inc., Flatiron Health, Tempus Labs Inc., Paige AI Inc., OncoHealth Corporation, Path AI Inc., Aidoc, AliveCor Inc., Sophia Genetics SA, Digital Diagnostics Inc., Prognos Health, Aidence, Kheiron Medical Technologies Limited, Zebra Medical Vision, Niramai, Enlitic Inc., Therapixel, Medial EarlySign Ltd., Freenome, SkinVision B.V. For further insights on the artificial intelligence in cancer diagnostics market, request a sample here.

What are the key trends in the artificial intelligence in cancer diagnostics market?

Major trend in the artificial intelligence in cancer diagnostics market - Ai-Powered Breakthrough In Cancer Diagnostics. For further insights on the artificial intelligence in cancer diagnostics market, request a sample here.

What are the major opportunities in the artificial intelligence in cancer diagnostics market? What are the strategies for the artificial intelligence in cancer diagnostics market?

For detailed insights on the major opportunities and strategies in the artificial intelligence in cancer diagnostics market, request a sample here.

How does the artificial intelligence in cancer diagnostics market relate to the overall economy and other similar markets?

For detailed insights on artificial intelligence in cancer diagnostics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the artificial intelligence in cancer diagnostics industry?

For detailed insights on the mergers and acquisitions in the artificial intelligence in cancer diagnostics industry, request a sample here.

What are the key dynamics influencing the artificial intelligence in cancer diagnostics market growth? SWOT analysis of the artificial intelligence in cancer diagnostics market.

For detailed insights on the key dynamics influencing the artificial intelligence in cancer diagnostics market growth and SWOT analysis of the artificial intelligence in cancer diagnostics industry, request a sample here.